Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Shuttle Pharmaceuticals Holdings will go public soon, but the exact IPO date is still unknown.
Stock Price: $4.50 - $5.00
Current IPO price range
Chart not available yet
Data will show when the stock starts trading.
Market Cap 63.29M
Revenue (ttm) n/a
Net Income (ttm) -1.81M
Shares Out 13.32M
EPS (ttm) -0.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About SHPH

Shuttle Pharmaceuticals is a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT). Although RT is a proven modality for treating cancers, by developing radiation sensitizers, we aim to increase cancer cure rates, prolong patient survival and improve quality of life when used as a primary treatment, or in combination with surgery, chemotherapy and immunotherapy. We currently have no FDA approved products and we have not yet applied for a new drug... [Read more...]

Industry Health Care
Founded 2012
CEO Anatoly Dritschilo, M.D.
Employees 5
Stock Exchange NASDAQ
Ticker Symbol SHPH
Full Company Profile

Financial Performance

Financial Statements


Shuttle Pharmaceuticals Holdings IPO Registration Document (S-1)

Shuttle Pharmaceuticals Holdings has filed to go public with an IPO on the NASDAQ